DAPK1 promoter methylation has been detected in majority of bladder cancer specimens [11, 13], transcriptional dyeregulation could be one of the major steps for DAPK1 downregulation in bladder cancer. This evidence concerns the gene DAPK1 and urinary bladder carcinoma.